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T-bet, but not Gata3, 
overexpression is detrimental in a 
neurotropic viral infection
Fumitaka Sato1,2,3,4, Eiichiro Kawai2,3, Nicholas E. Martinez2,3, Seiichi Omura1,2,3,4, 
 Ah-Mee Park1, Satoru Takahashi5,6,7,8, Keigyou Yoh5 & Ikuo Tsunoda1,2,3,4
Intracerebral Theiler’s murine encephalomyelitis virus (TMEV) infection in mice induces inflammatory 
demyelination in the central nervous system. Although C57BL/6 mice normally resistant to TMEV 
infection with viral clearance, we have previously demonstrated that RORγt-transgenic (tg) C57BL/6 
mice, which have Th17-biased responses due to RORγt overexpression in T cells, became susceptible 
to TMEV infection with viral persistence. Here, using T-bet-tg C57BL/6 mice and Gata3-tg C57BL/6 
mice, we demonstrated that overexpression of T-bet, but not Gata3, in T cells was detrimental in TMEV 
infection. Unexpectedly, T-bet-tg mice died 2 to 3 weeks after infection due to failure of viral clearance. 
Here, TMEV infection induced splenic T cell depletion, which was associated with lower anti-viral 
antibody and T cell responses. In contrast, Gata3-tg mice remained resistant, while Gata3-tg mice had 
lower IFN-γ and higher IL-4 production with increased anti-viral IgG1 responses. Thus, our data identify 
how overexpression of T-bet and Gata3 in T cells alters anti-viral immunity and confers susceptibility to 
TMEV infection.
Based on the differences of cytokine profiles, CD4+ T cells are classified into four subsets: T helper (Th) 1, Th2, 
Th17, and regulatory T cells (Tregs)1, 2. The following transcription factors contribute to the differentiation 
of murine Th cell subsets3: T-box transcription factor TBX21 (T-bet) for Th1 cells4, 5, GATA binding protein 
3 (Gata3) for Th2 cells6, 7, retinoic-acid-receptor-related orphan receptor-γt (RORγt) for Th17 cells, and fork-
head box P3 (Foxp3) for Tregs8–10. Among the Th cell subsets, Th1 and Th2 cells play protective roles in viral 
infections11–13. Th1 cells help cellular anti-viral immunity by producing interferon (IFN)-γ and interleukin (IL)-2, 
while Th2 cells help humoral anti-viral immunity by producing IL-4, IL-5, and IL-1314, 15. In some cases, how-
ever, Th1 and Th2 cells can play pathogenic roles in viral infections16. While uncontrolled Th1 cells can cause 
immune-mediated tissue damage (immunopathology)17, increased Th2 cells can also induce tissue damage by 
increasing viral replication and/or persistence (viral pathology), since Th2 cells suppress Th1-mediated anti-viral 
cellular immunity18. These findings have been mainly based on “loss-of-function” experiments, using either 
blocking antibodies against Th1/Th2 cytokines or knockout (KO) mice lacking Th1/Th2-related molecules.
A line of clinical reports have shown that “gain-of-function” mutations in signal transducer and activator of 
transcription 1 (STAT1) affect Th cell functions and alter susceptibility to autoimmune diseases and infections 
with microbes, including viruses19–22. Thus, we have established novel T-bet-transgenic (tg) mice and Gata3-tg 
mice that overexpress T-bet and Gata3 in T cells, as “gain-of-function” models23. Using these tg mice, we have 
demonstrated that Th1/Th2-related “gain-of-function” mutations alter susceptibility to some disease models24, 25. 
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In naïve T-bet-tg mice, T-bet overexpression favors generation of IFN-γ-producing CD4+ Th1 and CD8+ T cells, 
while the effects on immune-mediated diseases differ depending on disease models. T-bet-tg mice have disease 
exacerbation in animal models for contact dermatitis and glomerulonephritis, compared with wild-type mice26, 27. 
In contrast, in a collagen-induced arthritis (CIA) model, T-bet-tg mice do not have increased IFN-γ expression, 
while T-bet-tg mice neither develop CIA nor produce anti-collagen antibody, the latter of which is associated with 
suppression of Th17 cells28. On the other hand, Gata3-tg mice become susceptible to Th2-mediated diseases, such 
as allergic airway inflammation and pulmonary fibrosis, compared with wild-type mice29, 30. In viral infections, 
however, the influence of Th1 or Th2-biased responses remains unclear.
Theiler’s murine encephalomyelitis virus (TMEV) is a non-enveloped, positive-sense, single-stranded RNA 
virus that belongs to the family Picornaviridae31, 32. TMEV is divided into two subgroups, George’s disease 7 
(GDVII) and Theiler’s original (TO), based on the neurovirulence33. After intracerebral injection, the neuroviru-
lent GDVII subgroup viruses cause fatal acute polioencephalomyelitis regardless of mouse strains; most GDVII 
virus-infected mice die by 10 days post infection (p.i.). Since GDVII virus-infected mice cannot mount anti-viral 
immune responses, GDVII virus infection is considered to be a pure viral pathology model34, 35.
Intracerebral injection of less virulent TO subgroup viruses, including the Daniels (DA) and BeAn strains, 
does not cause fatal infection in any immunocompetent wild-type mouse strains31, 36. During the acute phase, 
all the mouse strains induce anti-viral immune responses and develop mild neurological signs32, 34. During 
the chronic phase, SJL/J mice that are a susceptible mouse strain develop TMEV-induced demyelinating dis-
ease (TMEV-IDD) in the central nervous system (CNS), which is mainly caused by immunopathology. Since 
TMEV-IDD resembles multiple sclerosis (MS) in humans clinically and histologically37, 38, DA or BeAn virus 
infection in SJL/J mice has been widely used as a viral model of MS. In contrast, resistant mouse strains, such as 
C57BL/6 mice, have no inflammation with complete viral clearance in 2–3 weeks p.i.39–41. The different suscepti-
bility to TMEV-IDD has been proposed to result from the different Th responses among mouse strains42, 43.
Resistant mouse strains, particularly C57BL/6 mice, have been used to clarify the key factors that are respon-
sible for viral clearance as well as immunopathology by blocking and modulating key molecules and immune 
cells to see whether such immunomodulation could alter susceptibility to TMEV infection. For example, major 
histocompatibility complex (MHC) class I-deficient mice on the resistant mouse background have been shown 
to become susceptible to TMEV-IDD, suggesting that CD8+ T cells play a key role to eradicate TMEV44–47. Using 
RORγt-tg mice that overexpress RORγt in T cells, we previously demonstrated that an increase in Th17 responses 
rendered C57BL/6 mice susceptible to TMEV-IDD48. TMEV-infected RORγt-tg mice had viral persistence, 
higher levels of IL-17 production, lower levels of IFN-γ production, and fewer CD8+ T cells without alteration 
in overall levels of anti-TMEV lymphoproliferative and antibody responses during the chronic phase. On the 
other hand, RORγt-tg mice developed a CNS disease similar to wild-type mice during the acute phase of TMEV 
infection clinically and histologically. Intracerebral injection of TMEV has also been used as a viral model of sei-
zures/epilepsy, since C57BL/6 mice, but not SJL/J mice, develop seizures during the first week of infection41, 49. In 
TMEV-induced seizures, the precise pathomechanism remains unclear.
The roles of Th1/Th2 immune responses in TMEV infection have been mainly investigated in mice whose 
Th1/Th2 cells were suppressed by “loss-of-function” approaches. These raised questions as to whether an increase 
in Th1/Th2 responses affects TMEV infection. We hypothesized that enhancement of Th1/Th2 responses could 
result in either a beneficial or detrimental outcome in TMEV infection by modulating anti-viral immune 
responses. In the present study, to determine the roles for T-bet and Gata3 overexpression in TMEV infection, we 
inoculated wild-type mice, T-bet-tg mice, and Gata3-tg mice on the resistant C57BL/6 mouse background with 
TMEV. Following intracerebral injection of less virulent DA virus, wild-type mice survived and did not develop 
TMEV-IDD. In contrast, T-bet-tg mice died of acute viral infection with lower levels of anti-viral humoral and 
cellular immune responses, which was associated with splenic T cell depletion. Gata3-tg mice remained resistant 
with a Th2-biased cytokine profile and increased anti-viral IgG1 production. Thus, T-bet overexpression may be 
detrimental in neurotropic viral infections.
Results
T-bet-tg mice die of infection with a less virulent strain of TMEV. To determine whether T-bet 
overexpression could alter susceptibility to TMEV infection, we infected wild-type mice and T-bet-tg mice on 
the C57BL/6 mouse background with the DA strain of TMEV (DA virus). Since DA virus does not cause fatal 
infection regardless of mouse strains40, 48, wild-type mice lost weight within a few days after DA virus infection 
and then gained weight with a 100% survival rate (Fig. 1A,B). In contrast, following DA virus infection, T-bet-tg 
mice had significant weight loss compared with wild-type mice 1 week p.i. and began to die 11 days p.i. After DA 
virus infection, 13 of the 15 (87%) T-bet-tg mice died with severe neurological signs; most T-bet-tg mice had 
hunched back and hind limb paresis followed by paraplegia, while some mice also developed spastic paralysis 
and priapism.
Since TMEV induces seizures in C57BL/6 mice during the first week of infection49, we monitored the clin-
ical signs of seizures in DA virus-infected mice. The incidence and maximum scores were similar between DA 
virus-infected wild-type mice and T-bet-tg mice [incidence: wild-type, 73% (29 of 40 mice); T-bet-tg, 62% (23 
of 37 mice), P = 0.3, chi-square (χ2) test; mean maximum Racine scale50, 51 scores ± standard error of the mean 
(SEM) in seized mice: wild-type, 5.0 ± 0; T-bet-tg, 4.7 ± 0.1].
T-bet-tg mice have higher viral replication with lower anti-TMEV immune responses. To 
address the cause of death in T-bet-tg mice after DA virus infection, we semi-quantified viral genome in the 
brains of wild-type mice and T-bet-tg mice 4 and 10 days p.i. using real-time polymerase chain reaction (PCR) 
for a pair of primers against the capsid protein VP2 of TMEV. Both wild-type mice and T-bet-tg mice had com-
parable viral replication in the brain 4 days p.i. (Fig. 1C). However, 10 days p.i., although wild-type mice had a 
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significant decrease in viral replication, T-bet-tg mice had similar levels of viral RNA in the brain between 4 and 
10 days p.i. In anti-viral cellular immunity, natural killer (NK) cells play a key role early, while T cell responses are 
observed as early as 5 days p.i. Thus, our results suggest that alteration of anti-viral T cells, but not NK cells, was 
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Figure 1. T-bet overexpression was detrimental in Theiler’s murine encephalomyelitis virus (TMEV) infection. 
(A) Body weight changes of wild-type mice (closed boxes) and T-bet-transgenic (tg) mice (open circles) after 
infection with the Daniels (DA) strain of TMEV (DA virus). **P < 0.01, Student t test. (B) Survival rates of 
wild-type mice and T-bet-tg mice infected with DA virus. **P < 0.01, chi-square (χ2) test. (C) Viral loads in the 
brains from wild-type mice and T-bet-tg mice 4 and 10 days after DA virus infection. **P < 0.01, Student t test. 
(D–H) Real-time polymerase chain reaction (PCR) analyses of Cd4 (CD4+ T cell marker), Cd8a (CD8+ T cell 
marker), Ifng [interferon (IFN)-γ], Gzmb (granzyme B), and Nkp46 (NK cell marker) in the brains from wild-
type mice and T-bet-tg mice 4 and 7 days after DA virus infection. *P < 0.05 and **P < 0.01, Student t test. (A, 
B) Values are the mean of 20 wild-type mice and 21 T-bet-tg mice from three independent experiments. (C–H) 
Values are the mean ± standard error of the mean (SEM) of four to eight mice per time point.
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likely responsible for the failure of viral clearance 10 days p.i. in T-bet-tg mice. While T cell-specific T-bet overex-
pression in T-bet-tg mice would mainly affect the generation of CD4+ Th1 and CD8+ T cells4, 26, 52, we quantified 
RNA expression of CD4 (CD4+ T cell marker), Cd8a (CD8+ T cell marker), Ifng (interferon-γ), Gzmb (granzyme 
B), as well as Nkp46 (NK cell marker) in the brain 4 and 7 days p.i. We found no significant differences in any of 
these RNA levels between wild-type mice and T-bet-tg mice, 4 days p.i. when NK cells play a central role in viral 
clearance (Fig. 1D–H); this is consistent with similar viral RNA levels between wild-type mice and T-bet-tg mice 
4 days p.i. On the other hand, 7 days p.i. when T cells play a key role in viral clearance, T-bet-tg mice had signifi-
cantly lower expression of CD4, Cd8a, Ifng, and Gzmb, but not Nkp46, compared with wild-type mice.
We quantified TMEV-specific lymphoproliferative responses (cellular immunity) and anti-TMEV antibody 
titers (humoral immunity) in wild-type mice and T-bet-tg mice 10 days p.i. using [3H]thymidine incorporation 
assays and enzyme-linked immunosorbent assays (ELISAs), respectively. The levels of TMEV-specific lymph-
oproliferation were significantly lower in T-bet-tg mice than in wild-type mice (Fig. 2A). T-bet-tg mice also had 
significantly lower titers of anti-TMEV IgG1 and IgG2c subclasses, compared with wild-type mice (Fig. 2B).
We also quantified the amounts of IFN-γ (Th1 cytokine), IL-4 (Th2 cytokine), and IL-17 (Th17 cytokine) pro-
duction from splenic mononuclear cells (MNCs) of wild-type mice and T-bet-tg mice 10 days p.i. using ELISAs. 
Splenic MNCs from both wild-type mice and T-bet-tg mice had substantial production of IFN-γ (Fig. 2C). In 
contrast, the amounts of IL-4 and IL-17 production from splenic MNCs were statistically lower in T-bet-tg mice, 
compared with wild-type mice.
T-bet-tg mice develop atrophy of the splenic T cell zone. Since we found impaired anti-TMEV cel-
lular responses in the spleen with lower titers of anti-TMEV antibodies in DA virus-infected T-bet-tg mice, we 
conducted histological examinations of the spleen in DA virus-infected wild-type mice and T-bet-tg mice using 
hematoxylin and eosin staining. DA virus-infected wild-type mice had normal morphology of the splenic red 
pulp and white pulp, the latter of which was composed of the B cell zone as well as the T cell zone in the periar-
terial lymphoid sheath (PALS) surrounding the central artery (Fig. 3A). On the other hand, following DA virus 
infection, T-bet-tg mice developed substantial atrophy of the splenic white pulp (Fig. 3B). Immunohistochemical 
staining for CD3 (T cell marker) and B220 (B cell marker) showed that the white pulp atrophy of T-bet-tg mice 
was due to substantial depletion of CD3+ T cells in the PALS with relative preservation of B cells, compared with 
wild-type mice (Fig. 3C–F). There was no substantial difference in F4/80+ macrophages in the red pulp between 
wild-type mice and T-bet-tg mice after DA virus infection (Supplementary Fig. 1). Since no histological changes 
were seen in the spleens of uninfected T-bet-tg mice (Supplementary Fig. 2), the depletion of T cells was likely 
triggered by DA virus infection.
Since T-bet-tg mice began to die 11 days p.i. (Fig. 1B), we harvested the CNS tissues of wild-type mice and 
T-bet-tg mice 10 days p.i. and compared the neuropathology between the two groups. Four-μm-thick sections 
of the brain and spinal cord were stained with Luxol fast blue to visualize the myelin and inflammation. In the 
brain, particularly in the hippocampus, both wild-type mice and T-bet-tg mice had severe neuronal loss with 
mild inflammation (Fig. 4A,B). The brain inflammation scores 10 days p.i. were similar between wild-type mice 
and T-bet-tg mice (Fig. 4E). In the spinal cords of the two groups, we found mild meningitis, perivascular cuffing 
(inflammation), and microglial nodules, but not demyelinating lesions (Fig. 4C,D). There were no statistical dif-
ferences in the spinal cord pathology scores between the two groups (Fig. 4F).
T-bet overexpression does not alter susceptibility to a neurovirulent strain of TMEV. Since we 
did not find increased CNS inflammation in T-bet-tg mice in the above experiments, immunopathology would 
not be the cause of death in T-bet-tg mice following DA virus infection. To see viral pathology alone could result 
in the fatality of T-bet-tg mice after TMEV infection, we infected wild-type mice and T-bet-tg mice with 0.1, 1, 
10, or 100 plaque forming units (PFUs) of the GDVII strain of TMEV (GDVII virus), which is neurovirulent. 
Following GDVII virus infection, mice cannot mount anti-viral acquired immune responses; infected mice die 
of viral pathology. In GDVII virus infection with 1 to 100 PFUs, most mice had encephalitic signs, such as weight 
loss, ruffled fur, and a hunched posture, around 6 days p.i. and died within 10 days p.i. (Table 1). The fatality, sur-
vival periods, and lethal dose (LD)50 titers were similar between wild-type mice and T-bet-tg mice (LD50 titers: 
wild-type, 0.40 PFUs; T-bet-tg, 0.24 PFUs). These results support that T-bet-tg mice would succumb to viral 
pathology, but not immunopathology, after DA virus infection as well as GDVII virus infection.
Gata3 overexpression does not alter susceptibility to TMEV infection. Using Th2-biased Gata3-tg 
mice, we determined whether an increase in Th2 immune responses could alter susceptibility to DA virus infec-
tion. We infected wild-type mice and Gata3-tg mice on the C57BL/6 mouse background with DA virus and 
monitored the clinical signs for 2 months. During the acute phase, both groups had similar incidence of seizures 
[wild-type, 66% (19 of 29 mice); Gata3-tg, 60% (20 of 33 mice), P = 0.6, χ2 test] and Racine scale scores (mean 
maximum scores ± SEM in seized mice: wild-type, 5 ± 0; Gata3-tg, 5 ± 0). The clinical course, severity, and weight 
changes were comparable between wild-type mice and Gata3-tg mice during the 2 months observation period 
(Supplementary Fig. 3).
To determine whether Gata3 overexpression could affect susceptibility to TMEV-induced pure viral pathol-
ogy, we infected wild-type mice and Gata3-tg mice with 0.1 to 100 PFUs of GDVII virus. Most mice developed 
encephalitic signs around 6 days p.i. and died within 10 days p.i. (Table 2). Both groups had similar fatality, sur-
vival periods, and LD50 titers (LD50 titers: wild-type, 0.87 PFUs; Gata3-tg, 0.74 PFUs).
Gata3-tg mice do not develop inflammatory demyelination in the CNS. Since we previously 
demonstrated that DA virus-infected RORγt-tg mice on the C57BL/6 mouse background developed inflam-
matory demyelination in the CNS with no clinical signs48, we compared the neuropathology between DA 
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Figure 2. T-bet overexpression decreased anti-viral immune responses and production of interleukin (IL)-4 and 
IL-17. (A) TMEV-specific lymphoproliferative responses of splenic mononuclear cells (MNCs) from wild-type 
mice (black bar) and T-bet-tg mice (white bar) 10 days after DA virus infection. Values of lymphoproliferative 
responses to TMEV are expressed as Δcpm: (mean of experimental cpm in TMEV-specific stimulation) − (mean 
of control cpm). Values are the mean + SEM of three pools of spleens from two mice (six mice per group). (B) 
Enzyme-linked immunosorbent assays (ELISAs) of anti-TMEV IgG1 and IgG2c subclasses in sera from wild-type 
mice and T-bet-tg mice10 days after DA virus infection. The dotted line shows the detection limit. Values are the 
mean + SEM of six mice per group. (C) ELISAs of IFN-γ, IL-4, and IL-17 production from mitogen-stimulated 
splenic MNCs of DA virus-infected wild-type mice and T-bet-tg mice at day 10. Values are the mean + SEM 
from two independent experiments (five to six mice per group per experiment). (A–C) The experiments were 
conducted twice independently. *P < 0.05 and **P < 0.01, Student t test.
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virus-infected wild-type mice and Gata3-tg mice. During the acute phase (1 week p.i.), both wild-type mice and 
Gata3-tg mice had severe neuronal loss with infiltration of inflammatory cells in the brain, particularly in the 
region CA1 (pyramidal cell layer) of the hippocampus (Fig. 5A,B). The brain inflammation scores were compa-
rable between the two groups (Supplementary Fig. 4A). In the spinal cord, 1 week p.i., both wild-type mice and 
Gata3-tg mice developed meningitis and perivascular cuffing, but not demyelination, and had similar pathology 
scores (Fig. 5C,D and Supplementary Fig. 4B). During the chronic phase (2 months p.i.), both wild-type mice and 
Gata3-tg mice had similar hippocampal atrophy in the brain, which is shown by neuronal loss in the region CA1 
(Supplementary Fig. 5A,B). In the spinal cord, both wild-type mice and Gata3-tg mice did not develop demyeli-
nating lesions, 2 month p.i. (Supplementary Fig. 5C,D).
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Figure 3. DA virus infection induced the change in spleen immune-architecture in T-bet-tg mice, but not 
in wild-type mice. (A,B) Hematoxylin and eosin stain showed that DA virus-infected T-bet-tg mice had 
small follicles (white pulp, WP, dotted line) with depletion of cells in the periarterial lymphoid sheath (PALS) 
(B), which formed a mass around the central artery (*) in DA virus-infected wild-type mice (A). (C–F) 
Immunohistochemistry against CD3 (T cell marker) and immunohistochemistry against B220 (B cell marker) 
showed depletion of T cells in the PALS with relative preservation of B cells in the white pulp in DA virus-
infected T-bet-tg mice (D,F), compared with DA virus-infected wild-type mice (C,E). Spleen tissue sections 
(scale bar = 100 μm) were from DA virus-infected wild-type mice and T-bet-tg mice. RP, red pulp. Each group 
was composed of six to ten mice. Tissue sections are representative of two independent experiments.
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Gata3-tg mice mount anti-viral cellular and humoral responses comparable to wild-type 
mice. Since Gata3-tg mice remained as resistant to TMEV infection during the acute and chronic phases 
as wild-type mice, we anticipated that viral clearance and anti-viral immune responses could also be similar 
between the two mouse strains. We found that the levels of viral RNA in the brain 1 week p.i. were similar between 
wild-type mice and Gata3-tg mice (Fig. 6A). Both wild-type mice and Gata3-tg mice eradicated the virus from 
the CNS 2–3 weeks p.i. (data not shown). During the acute phase of TMEV infection, resistant mouse strains 
Wild-type T-bet-tg
0
1
2
3
4
5
6
 
B
ra
in
 p
at
ho
lo
gy
 s
co
re
E F
Demyelination Meningitis Cuffing Overall
0
5
10
15
20
Sp
in
al
 c
or
d 
pa
th
ol
o
gy
 s
co
re
 Wild-type
 T-bet-tg
N.D.
Wild-type
Br
ai
n
T-bet-tg
Sp
in
al
 c
o
rd
BA
DC
Figure 4. T-bet overexpression did not alter neuropathology in TMEV infection. (A–D) Luxol fast blue stains 
of the central nervous system (CNS) tissue sections from wild-type mice and T-bet-tg mice 10 days after DA 
virus infection. In the brain sections (scale bar = 300 μm), arrows and arrowheads show perivascular cuffing 
and neuronal loss, respectively. In the spinal cord sections (scale bar = 200 μm), paired arrows, arrows, and 
paired arrowheads show meningitis, perivascular cuffing, and neuronophagia, respectively. Tissue sections are 
representative of two independent experiments. (E,F) Pathology scores of the CNS tissue sections from DA 
virus-infected wild-type mice (black bar) and T-bet-tg mice (white bar) at day 10. N.D., not detectable. The 
experiments were conducted twice independently. Values are the mean + SEM of eight wild-type mice and nine 
T-bet-tg mice.
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PFUb
Wild-typea T-bet-tg
Mortalityc
Survival 
days ± SEMd Mortality
Survival 
days ± SEM
100 4/4 6.0 ± 0.4 4/4 6.5 ± 0.3
10 11/11 6.8 ± 0.4 12/12 6.8 ± 0.3
1 5/6 8.0 ± 1.0 5/5 8.6 ± 1.6
0.1 0/5 — 1/5 9.0 ± 0.0
Table 1. Mortality and survival days of wild-type mice and T-bet-tg mice in GDVII virus infection. aMice 
were infected with the George’s disease 7 (GDVII) strain of Theiler’s murine encephalomyelitis virus (TMEV) 
intracerebrally. bPlaque forming units (PFUs) of virus inoculated. cNumber of dead mice/total number of mice 
inoculated with virus. dMean survival days ± standard error of the mean (SEM) in dead mice following GDVII 
virus infection.
PFUb
Wild-typea Gata3-tg
Mortalityc
Survival 
days ± SEMd Mortality
Survival 
days ± SEM
100 6/6 6.2 ± 0.2 5/5 6.8 ± 0.6
10 6/7 6.8 ± 0.3 5/5 6.6 ± 0.4
1 8/14 9.5 ± 0.7 4/8 8.3 ± 0.3
0.1 0/5 — 1/4 11 ± 0.0
Table 2. Mortality and survival days of wild-type mice and Gata3-tg mice in GDVII virus infection. aMice were 
infected with the GDVII strain of TMEV intracerebrally. bPFUs of virus inoculated. cNumber of dead mice/
total number of mice inoculated with virus. dMean survival days ± SEM in dead mice following GDVII virus 
infection.
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Figure 5. Gata3 overexpression did not alter neuropathology in TMEV infection. (A–D) Luxol fast blue stains 
of the CNS tissue sections from wild-type mice and Gata3-tg mice 1 week after DA virus infection. In the brain 
sections (scale bar = 300 μm), arrows and arrowheads show perivascular cuffing and neuronal loss, respectively. 
In the spinal cord sections (scale bar = 200 μm), paired arrows and arrows show meningitis and perivascular 
cuffing, respectively. Tissue sections are representative of two independent experiments.
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have been shown to mount substantial cellular and humoral immune responses, both of which contribute to viral 
clearance48. We found that both wild-type mice and Gata3-tg mice mounted similar levels of anti-TMEV cellular 
immune responses by [3H]thymidine incorporation assays (Fig. 6B). Anti-TMEV antibody responses, including 
IgM, IgG1 and IgG2c, were also similar between wild-type mice and Gaga3-tg mice during the acute phase, while 
only anti-TMEV IgG1 titers were statistically higher in Gata3-tg mice during the chronic phase (Fig. 6C).
Using ELISAs, we also determined cytokine profiles in wild-type mice and Gata3-tg mice 1 week and 2 months 
p.i. The levels of IFN-γ production were lower in Gata3-tg mice (2 months p.i., P < 0.05), while the levels of IL-4 
production were higher in Gata3-tg mice (1 week p.i., P < 0.01), compared with wild-type mice (Fig. 6D). On the 
other hand, there were no significant differences in the levels of IL-13 or IL-17 production between wild-type 
mice and Gata3-tg mice.
Discussion
Clinically, immune system imbalance has been reported to be associated with susceptibility to human diseases. 
For example, Th1- or Th17-biased responses play a pathogenic role in autoimmune diseases, while Th2-biased 
responses contribute to the pathogenesis of allergic diseases53. Recently, there have been reports that patients with 
“gain-of-function” mutations in STAT1 gene had normal Th1 immune responses, but impaired Th17 immune 
responses, resulting in severe infections with viruses, including a herpesvirus and parapoxvirus, as well as fungi21, 22. 
In this study using T-bet-tg mice and Gata3-tg mice on the resistant C57BL/6 mouse background, we demon-
strated that T-bet, but not Gata3, overexpression in T cells was detrimental in neurotropic TMEV infection. 
Despite being infected with a less virulent DA virus, most T-bet-tg mice developed a fatal disease with impaired 
viral clearance. Although TMEV-infected T-bet-tg mice had a Th1-biased cytokine profile, the reason why an 
expected increase in the Th1 responses was not seen in the T-bet-tg mice was likely due to severe depletion of T 
cells in the spleen in T-bet tg mice following TMEV infection. The T cell depletion can explain low anti-viral cel-
lular immune responses, while low Th2/Th17 cytokine production that was also seen in the T-bet-tg mice could 
further result in the poor anti-viral antibody production.
“Loss-of-function” studies using neutralizing antibodies against Th1-associated cytokines have shown that 
Th1 immune responses play contrasting roles in TMEV infection. Pullen et al.54 demonstrated that treatment with 
IFN-γ-neutralizing monoclonal antibody (mAb) in TMEV-infected susceptible SJL/J mice accelerated the disease 
course and exacerbated the CNS pathology, compared with control mice, suggesting that Th1 cells play a protec-
tive role. On the other hand, Pullen et al.54 also showed that TMEV-infected mice with IFN-γ infusion intracere-
brally showed clinical signs within 3 days of IFN-γ injection (8 days p.i.), suggesting a pathogenic role of Th1 cells. 
Furthermore, Inoue et al.17 demonstrated that TMEV-infected susceptible SJL/J mice with IL-12-neutralizing 
mAb treatment, which decreases Th1 cell differentiation, had a delay in the onset of TMEV-IDD with less severe 
inflammatory demyelination in the CNS, compared with control mice, suggesting that Th1 cells play a pathogenic 
role. In this study, we demonstrated that T-bet-tg mice infected with DA virus intracerebrally had Th1-biased 
responses and most mice died by 18 days p.i. Thus, T-bet overexpression seems to be detrimental in TMEV 
infection.
We demonstrated that DA virus-infected T-bet-tg mice had significantly lower anti-TMEV antibody titers, 
while DA virus-infected Gata3-tg mice had higher anti-TMEV IgG1 titers, compared with wild-type mice. These 
findings may be due to the difference in Th2 cytokine responses, which help antibody production; we found the 
ratios of Th1 (IFN-γ)/Th2 (IL-4) cytokine responses were higher in T-bet-tg mice and lower in Gata3-tg mice 
(data not shown). The differences of anti-TMEV antibody titers due to the different Th1/Th2 cytokine balance 
may affect viral clearance in the CNS. In addition, T-bet-tg mice had a significant decrease in IL-17 produc-
tion. The decreased Th17 responses may also contribute to decreased anti-TMEV antibody responses, since Th17 
cells have been shown to facilitate antibody production55. Since antibodies have been shown to be taken up by 
neurons56, antibodies could contribute to viral clearance from the CNS in neurotropic viral infections. In contrast, 
since neurons express neither MHC class I nor MHC class II molecules during inflammation as well as steady 
state57, 58, anti-viral T cells could not kill virus-infected neurons. For example, in Sindbis virus infection, passive 
transfer of anti-viral antibodies into severe combined immunodeficient (SCID) mice, which have neither func-
tional T cells nor antibodies, resulted in viral clearance from the CNS, while adoptive transfer of virus-specific T 
cells into SCID mice had no effect59.
In TMEV infection, Fujinami et al.60 demonstrated that anti-TMEV mAb treatment of athymic nude mice, 
which cannot mount neither cellular nor humoral immunity, protected from the lethal infection with a significant 
reduction of infectious virus in the CNS. Similarly, Welsh et al.61 demonstrated that CD4+ T cell-depleted CBA 
mice failed to produce anti-TMEV antibodies and died by 3 weeks p.i. On the other hand, a lack of anti-TMEV 
antibody responses does not necessarily result in fatal encephalitis. TMEV-infected MHC class II-deficient mice 
on the C57BL/6 mouse background62 cannot produce anti-TMEV antibodies, which lead to viral persistence, but 
not fatal acute encephalitis63. TMEV-induced encephalitis was observed in B cell-deficient (μMT) C57BL/6 mice 
only if the mice depleted of CD8+ cells, while anti-TMEV serum transfer into anti-CD8 mAb-treated μMT mice 
restored resistance to encephalitis44. TMEV-infected β2-microglobulin mice lacking functional CD8+ T cells on 
the C57BL/646 or C57BL/6 × 12945, 47 mouse background also failed to clear TMEV, leading to viral persistence, 
while these mice did not succumb to acute encephalitis. Taken together, TMEV-infected mice generally develop 
fatal acute encephalitis when the mice have neither antibody (which requires CD4+ T cell help) nor CD8+ T cell 
responses. This is consistent with fatal encephalitis seen in our TMEV-infected T-bet-tg mice whose anti-viral 
antibody and CD4+/CD8+ T cell responses were significantly decreased.
In this study, we demonstrated that TMEV infection triggered atrophy in the splenic white pulp due to deple-
tion of T cells in T-bet-tg mice. Since TMEV cannot infect lymphocytes64, lymphoid depletion could be likely 
caused in a bystander fashion. Virus-induced lymphoid depletion has been observed in several viral infections, 
particularly viral hemorrhagic fevers (VHFs), where the virus infects macrophages and dendritic cells, but not 
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Figure 6. Gata3-tg mice and wild-type mice mounted similar anti-viral immune responses. (A) Real-time PCR 
analyses of the capsid protein VP2 of TMEV in the brains from wild-type mice (black bar) and Gata3-tg mice 
(white bar) 1 week after DA virus infection. Values are the mean + SEM of five to eight mice. (B) TMEV-specific 
lymphoproliferative responses of splenic MNCs from wild-type mice and Gata3-tg mice 1 week and 2 months 
after DA virus infection. Values of lymphoproliferative responses to TMEV are expressed as Δcpm: (mean of 
experimental cpm in TMEV-specific stimulation) − (mean of control cpm). Values are the mean + SEM of three 
to four pools of spleens from two to three mice per time point. (C) ELISAs of anti-TMEV IgM, IgG1, and IgG2c 
subclasses in sera from wild-type mice and Gata3-tg mice 1 week and 2 months after DA virus infection. The 
dotted line shows the detection limit. Values are the mean + SEM of four to seven mice per group. (D) ELISAs of 
IFN-γ, IL-4, IL-13, and IL-17 production from mitogen-stimulated splenic MNCs of wild-type mice and Gata3-tg 
mice 1 week and 2 months after DA virus infection. Values are the mean + SEM of five to seven mice per time 
point. (A–D) The experiments were conducted twice independently. *P < 0.05 and **P < 0.01, Student t test.
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lymphocytes, leading to lymphoid depletion65. The precise mechanism of the virus-induced lymphoid depletion 
in VHF is unclear, but is likely to depend on multiple pathways, including dysfunction of dendritic cells66. Since 
TMEV infects monocyte-macrophage lineage cells, dysfunction of macrophages and dendritic cells may also play 
a role in lymphoid depletion in TMEV-infected T-bet-tg mice.
TMEV-infected T-bet-tg mice had a significant reduction of CD4, CD8a, Ifng, and Gzmb, but not Nkp46, 
expression in the brain with decreased anti-TMEV cellular responses; following TMEV infection, T-bet-tg mice 
had impaired acquired immunity but not innate immunity, which was associated with splenic T cell depletion. 
The impaired TMEV-specific lymphoproliferation in TMEV-infected T-bet-tg mice would result in a significant 
decrease in anti-TMEV antibody titers, since Th cells have been shown to contribute to antibody production in 
the white pulp61. Consistent with these findings, Kondo et al.28 demonstrated that T-bet-tg mice became resistant 
to a CIA model with lower titers of antibody against type II collagen. The absolute number of Th cells in the spleen 
tended to be lower in T-bet-tg mice than in wild-type mice after immunization. Furthermore, naïve T-bet-tg mice 
had a significant decrease in the absolute number of thymocytes, compared with wild-type mice. These find-
ings suggest that T-bet-tg mice may be immunocompromised and that viral pathology may cause fatal infection 
in T-bet-tg mice, since T-bet-tg mice had failure of viral clearance associated with impaired acquired immune 
responses to DA virus with T cell depletion in the spleen.
During the first week of TMEV infection, C57BL/6 mice develop seizures; anti-viral innate immunity, but 
not acquired immunity, has been shown to play a pathogenic role in TMEV-induced seizures67–69. In this study, 
there were no statistical differences in the incidence of DA virus-induced seizures between wild-type mice versus 
T-bet-tg mice and Gata3-tg mice. Wild-type mice and the two tg mice had seizures from days 3 to 8 after DA virus 
infection mainly, when innate immunity plays a role in viral clearance. Furthermore, no statistical differences 
were seen in the levels of Nkp46, Ifng or Gzmb in the brain 4 days p.i. between wild-type mice versus T-bet-tg 
mice. These findings would be reasonable, since T-bet or Gata3 overexpression in T cells in T-bet-tg mice or 
Gata3-tg mice unlikely affects innate immune responses.
Neurovirulent GDVII virus causes fatal acute polioencephalomyelitis regardless of mouse strains: infected 
mice have severe weight loss and encephalitic signs, including hunched back and ruffled fur, and die within 10 
days of the infection70. Viral pathology has been shown to cause the fatal outcome here, since infected mice failed 
to induce anti-viral acquired immune responses34. In this study, we demonstrated that the survival periods and 
LD50 titers were similar between wild-type mice versus T-bet-tg mice and Gata3-tg mice. These results could be 
reasonable in GDVII virus infection, which is a pure viral pathology model34.
In summary, we demonstrated that T-bet overexpression in T cells was detrimental in TMEV infection due to 
impaired acquired immune responses to TMEV, which were associated with atrophy of the spleen. On the other 
hand, Gata3 overexpression in T cells had some beneficial effects on TMEV infection by increasing anti-viral 
IgG1 production with a Th2-biased cytokine profile. Thus, an individual, who has overexpression of T-bet, may 
be more susceptible to viral infections, while an individual, who has overexpression of Gata3, may be resistant to 
viral infections.
Methods
Animal experiments. To generate T-bet-tg mice or Gata3-tg mice, a full-length cDNA encoding the murine 
T-bet or Gata3 protein was inserted into a VA CD2 transgene cassette that contained the upstream gene regu-
latory region and locus control region of the human CD2 gene26, 71. T-bet-tg mice and Gata3-tg mice preferen-
tially overexpress T-bet and Gata3 in T cells, respectively. T-bet-tg mice and Gata3-tg mice were maintained as 
heterozygotes for the transgene by being bred with wild-type C57BL/6 mice24. The mice were maintained under 
specific pathogen-free conditions in our animal care facility at Louisiana State University Health Sciences Center-
Shreveport (LSUHSC-S) and Kindai University Faculty of Medicine (Osaka, Japan). All experimental procedures 
were reviewed and approved by the Institutional Animal Care and Use Committee of LSUHSC-S and Kindai 
University Faculty of Medicine, and performed according to the criteria outlined by the National Institutes of 
Health (NIH).
Six to eight-week-old wild-type mice (littermate controls), T-bet-tg mice, and Gata3-tg mice were infected 
intracerebrally with 2 × 105 PFUs of DA virus or 0.1 to 100 PFU of GDVII virus70. Clinical signs of seizures were 
evaluated using the Racine scale: 1, mouth and facial movements; 2, head nodding; 3, forelimb clonus; 4, rearing; 
and 5, rearing and falling50, 51. The LD50 titers were calculated using the Reed and Muench calculation of the 50% 
endpoint72.
Real-time PCR. Following perfusion with phosphate-buffered saline (PBS) into the heart, the brain was har-
vested, frozen with liquid nitrogen, and then homogenized with TRI-reagent (Molecular Research Center, Inc., 
Cincinnati, OH) using a Polytron PT1200E homogenizer (Kinematica AG, Luzern, Switzerland)35. RNA was iso-
lated from the homogenate using a Qiagen RNeasy Mini Kit (Qiagen, Inc., Valencia, CA), according to the man-
ufacturer’s instruction. We reverse-transcribed 1 µg of total RNA into cDNA using the ImProm-IITM Reverse 
Transcription System (Promega, Corp. Madison, WI)73. Using 50 ng of cDNA, real-time PCR was conducted 
with an RT2 Fast SYBR Green/Flurescein qPCR Master Kit (Qiagen) and the MyiQTM2 Real Time PCR Detection 
System (Bio-Rad Laboratories, Inc., Hercules, CA). To determine viral replication and gene expression related 
to CD4+ T cells, CD8+ T cells, and NK cells in the brain, we used the following primer pairs: the capsid protein 
VP2 of TMEV (Real Time Primers, LLC, Elkins Park, PA), forward (5′-TGGTCGACTCTGTGGTTACG-3′) 
and reverse (5′-GCCGGTCTTGCAAAGATAGT-3′)74; Cd4 (Eurofins Genomics, Tokyo, Japan), forward 
(5′-TCCTAGCTGTCACTCAAGGGA-3′) and reverse (5′-TCAGAGAACTTCCAGGTGAAGA-3′); Cd8a (Eurofins 
Genomics), forward (5′-TGCTGTCCTTGATCATCACTCT-3′) and reverse (5′-ACTAGCGGCCTGGGACAT-3′); 
Ifng (Real Time Primers), forward (5′-CAAAAGGATGGTGACATGAA-3′) and reverse (5′-TTGGCAA 
TACTCATGAATGC-3′); Gzmb (Real Time Primers), forward (5′-TGGCCTTACTTTCGATCA AG-3′) and reverse 
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(5′-CAGCATGATGTCATTGGAGA-3′); and Nkp46 (Eurofins Genomics), forward (5′-ATGCTGCCAA 
CACTCACTG-3′) and reverse (5′-GATGTTCACCGAGTTTCCATTTG-3′). A primer pair for phospho-
glycerate kinase 1 (Pgk1) (Real Time Primers) was used as a housekeeping gene for normalization; forward 
(5′-GCAGATTGTTTGGAATGGTC-3′) and reverse (5′-TGCTCACATGGCTGACTTTA-3′).
Lymphoproliferative responses to TMEV. Lymphoproliferation was assessed as described 
previously48. We harvested the spleen and isolated MNCs from the spleen pools of two to three TMEV-infected 
mice using Histopaque®-1083 (Sigma-Aldrich, St. Louis, MO). Splenic MNCs were cultured with RPMI1640 
medium (Mediatech, Inc., Manassas, VA) supplementing 10% fetal bovine serum (FBS) (Mediatech), 2 mM 
L-glutamine (Mediatech), 50 mM β-mercaptoethanol (Sigma-Aldrich), and 1% antibiotic-antimycotic solution 
(Mediatech), at 2 × 105 cells/well in 96-well plates (Corning Inc., Corning, NY) and stimulated with 2 × 105 
cells/well of TMEV-infected antigen-presenting cells (TMEV-APCs) or mock-infected antigen-presenting cells 
(control-APCs) for 5 days. TMEV-APCs were made from whole spleen cells infected in vitro with TMEV at a 
multiplicity of infection (MOI) of 1, while control-APCs were made from mock-infected whole spleen cells. Both 
TMEV-APCs and control-APCs were incubated overnight and irradiated with 2,000 rads using a 137Cs irradiator 
(J.L. Shepherd & Associates, San Fernando, CA). To assess the levels of lymphoproliferative responses, [3H]thy-
midine (PerkinElmer, Inc., Waltham, MA) was added in the culture system at the concentration of 1 μCi/well for 
the last 24 hours. The incorporated radioactivity was measured using a Wallac 1409 Liquid Scintillation Counter 
(PerkinElmer). All cultures were performed in triplicate and the data were expressed as Δcpm: (mean of cpm in 
TMEV-APC stimulation) − (mean of cpm in control-APC stimulation).
ELISAs for anti-TMEV antibodies and cytokines. The titers of serum anti-TMEV antibodies were 
quantified by ELISAs, as described previously41. Blood was drawn from the heart and spun down for harvesting 
serum. We coated 96-well flat-bottom Nunc-Immuno plates (Thermo Fisher Scientific Inc., Waltham, MA) with 
10 μg/ml of TMEV antigen. Eleven serial two-fold dilutions from 27 of serum were added to the plates followed 
by a peroxidase-conjugated anti-mouse IgM (Stressgen Bioreagents Corp., Victoria, Canada), IgG1 (Thermo 
Fisher Scientific), or IgG2c antibody (Thermo Fisher Scientific). Immunoreactive complexes were detected with 
o-phenylendiamine dihydrochloride (Sigma-Aldrich). The absorbances were read at 492 nm using a Multiskan 
MCC/340 Microplate Reader (Thermo Fisher Scientific). An absorbance higher than the mean + two stand-
ard deviations of naïve serum samples at a dilution of 27 was used as the standard for evaluating anti-TMEV 
antibody titers48.
Cytokine ELISAs were conducted as described previously39. MNCs from the spleen pools of two 
TMEV-infected mice were cultured at 8 × 106 cells/well in 6-well plates (Corning) and stimulated with 5 μg/ml 
of concanavalin A for 48 hours. Culture supernatants were harvested and stored at −80 °C until examined. The 
amounts of IFN-γ (BD Biosciences, San Diego, CA), IL-4 (BD Biosciences), IL-13 (Thermo Fisher Scientific), and 
IL-17A (BioLegend, San Diego, CA) production in the culture supernatants were quantified using the ELISA kits, 
according to the manufacturer’s instructions.
Histology and immunohistochemistry. TMEV-infected mice were perfused with PBS followed by a 4% 
paraformaldehyde (PFA, Sigma-Aldrich) solution in PBS75. After the PFA fixation, the spleen was harvested from 
mice and embedded in paraffin. The spleen tissues were sliced at 4 μm-thick using an HM 325 Rotary Microtome 
(Thermo Fisher Scientific) and stained with hematoxylin (Electron Microscopy Sciences, Hatfield, PA) and 
eosin (Thermo Fisher Scientific) to visualize the general architecture. T cells, B cells, and macrophages in spleen 
sections were visualized by immunohistochemistry with anti-CD3 antibody (Biocare Medical, Pacheco, CA), 
anti-B220 antibody (Bio-Rad Laboratories), and anti-F4/80 antibody (eBiosciences, San Diego, CA), respectively, 
using a Histofine MAX-PO kit (Nichirei Biosciences, Tokyo, Japan). Antigen retrieval was conducted by citrate 
buffer (pH 6, Dako, Carpinteria, CA) and proteinase K (AMRESCO LLC, Solon, OH) prior to incubation with 
antibodies to CD3 and F4/80, respectively.
After the PFA fixation, the brain and spinal cord were divided into five coronal slabs and 10 to 12 transversal 
segments, respectively, and embedded in paraffin. The CNS tissues were sliced at 4 μm-thick and stained with 
Luxol fast blue (Solvent blue 38; Sigma-Aldrich) for myelin visualization. Histological scoring of the CNS was 
performed as described previously39. A brain pathology score was determined by combining pathology scores 
of meningitis, perivascular cuffing, and demyelination. These scores were evaluated as follows: meningitis: 0, no 
meningitis; 1, mild cellular infiltration; 2, moderate cellular infiltration; and 3, severe cellular infiltration; perivas-
cular cuffing: 0, no cuffing; 1, 1 to 10 lesions; 2, 11 to 20 lesions; 3, 21 to 30 lesions; 4, 31 to 40 lesions; and 5, over 
40 lesions; demyelination: 0, no demyelination; 1, mild demyelination; 2, moderate demyelination; and 3, severe 
demyelination. For scoring of spinal cord sections, each spinal cord section was divided into four quadrants: the 
ventral funiculus, the dorsal funiculus, and each lateral funiculus. Any quadrant containing meningitis, perivas-
cular cuffing, or demyelination was given a score of 1 in that pathological class. The total number of positive quad-
rants for each pathological class was determined and then divided by the total number of quadrants present on 
the slide and multiplied by 100 to give the percent involvement for each pathological class. An overall pathology 
score was also determined by giving a positive score if any pathology was seen in the quadrant, and presented as 
the percent involvement.
Statistical analysis. Using the OriginPro 8.1 (OriginLab Corporation, Northampton, MA), the Student t 
test and Mann-Whitney U test were conducted for parametric data and nonparametric data, respectively. The 
χ2 test was conducted for categorical data using the GraphPad software (GraphPad Software, Inc., La Jolla, CA).
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